R&D budgets across the world have surprisingly struggled
to take serious note of neuro-science’s explosive growth, and neurotech briefly
remained under-funded, awaiting a policy push. Until recently, that is. Today,
at least five international neuroscience initiatives are already going
full-steam ahead towards a brighter neurotech future, all of which are less
than three years old. The initiatives are in addition to ambitious brain
projects and specialized neuroscience foundations and non-profit organizations
around the world, some of which were established precisely to relieve R&D
budget bottlenecks.
Israel’s President Shimon Peres was one of the first global
leaders to see the immense potential of neurotechnology and to lay foundations
for Israel’s now burgeoning Israel Brain Technologies initiative, officially founded
in 2011. Many figures and organizations quickly followed suit, in what has now
become a global gold rush to fill the emerging power vacuum on the throne of
world brain leaders. Table 1 summarizes active neuroscience initiatives and
active brain foundations around the world.
TABLE 1. A SELECTION OF GLOBAL NEUROSCIENCE INITIATIVES AND
FOUNDATIONS
Initiative/ Foundation
|
Country
|
Est.
|
Budget
|
Goals/Objectives/Focus
|
|
INITIATIVES
|
|||||
Brain Research Through Advancing Innovative
Technologies (B.R.A.I.N)
|
USA
|
2013
|
$100 million for first year;
commitment for 10 years—subsequent budget to be drawn at later stages
|
Create an elaborate brain map and invest in novel
brain mapping technologies
|
|
Fattah Brain Initiative (Now part of B.R.A.I.N)
|
USA
|
2011
|
Significantly increase
federal funding of neuroscience, which the initiative accomplished with the B.R.A.I.N. project
|
||
Human Brain Project
|
EU
|
2013
|
€1.19 billion over 10 years
|
Develop world’s most elaborate ICT (Information and
Communication Technology) Infrastructure in order to provide powerful
research tools for neuroscience and to establish and accelerate a global
collaboration in brain research
|
|
Israel Brain Technologies (IBT)
|
Israel
|
2011
|
N/A; $1 million prize for
international innovative neurotechnology
|
Make Israel a leading neurotech hub
of the world; fund most innovative global neuro-technologies
|
|
National Neurotechnology Initiative Act (NNTI)
|
USA
|
2007
|
$200 million
|
Open up innovation bottlenecks by coordinating
across federal agencies on all neuro-developments, and establishing
multi-agency cooperation in neuroscience
|
|
Brain Canada Multi-Investigator Research
Initiative (MIRI)
|
Canada
|
2012
|
CA$ 1.5 million per project, over three years
|
Support up to five
multidisciplinary teams in the sphere of neuroscience research over three
years
|
|
Palestinian Neuroscience Initiative
|
Palestine
|
2010
|
Approx.
$300,000
|
Build
infrastructure for neuroscience research in Palestine, Augment research
training for a new generation of Palestinian medical students and doctors, in
cooperation with elite institutions worldwide
|
NORBRAIN – NORWAY BRAIN INITIATIVE
|
Norway
|
2012
|
NOK 80 million (US $13.7 million)
|
Set up state-of-the-art
neuroscience equipment across a broad spectrum of molecular and systems
neuroscience in Norway
|
FOUNDATIONS
|
||||
The Dana Foundation*
|
USA
|
1950
|
Approx. $10 million revenue
(2011)
|
Advance brain research and educate
the public in a responsible manner about research’s potential
|
The Brain Canada Foundation (Brain
Canada)†
|
Canada
|
2010
|
CA$100 million
|
Support Canadian neuroscience, accelerate
discoveries to improve the health and quality of life for Canadians who
suffer from brain disorders
|
The Israel Society For
Neuroscience#
|
Israel
|
1992
|
N/A
|
Collect, share and disseminate
information about Israel’s neuro-developments
|
Brain Foundation Australia#
|
Australia
|
1970
|
N/A
|
Fund world-class research Australia-wide into
neurological disorders, brain disease and brain injuries
|
Global Neuroscience Initiative
Foundation (GNIF)#
|
USA
|
2003
|
N/A
|
Advance neurological and
mental health patient welfare, education, and research; promote free and
open-access distribution of brain related information
|
* Private philanthropic organization
† National charitable organization
# Non-profit charity organization
THE B.R.A.I.N INITIATIVE
On April 2, 2013 President Barack Obama unveiled the BRAIN (which
coincidentally spells Brain Research through Advancing Innovative
Neurotechnologies) initiative, whose final and uttermost objective is to
visualize, map, understand and reconstruct the activity of every single neuron
in the brain. This knowledge will in the future be applied to the development
of new technologies and the treatment of quickly expanding array of
neurological disorders.
The initiative was launched with US$ 100 million in the
President’s Fiscal Year 2014 Budget, which pales in comparison with the $5.5
billion the NIH spends on neuroscience annually, but significantly outshines
the measly $28 million spent on the human genome project in its first year of
operation. BRAIN’s near-sighted primary goal will be to sponsor ongoing brain
mapping projects, such as the Human Connectome Project, and technologies which
will facilitate the projects’ progress. In his BRAIN inauguration speech, the
President called on academic institutions, industry, foundations, researchers
and philanthropists to help in identifying realistic goals and objectives for
the initiative.
In addition to the governmental budget, philanthropic and
non-profit organizations have made additional support pledges to the
initiative. Foundations which have already announced dedicated commitment to
the plan and related projects are: The Allen Institute ($60 million), the
Howard Hughes Medical Institute ($30 million annually), the Kavli Foundation
($4 million annually) and Salk Institute for Biological Studies ($28 million).
Considering the fact that a single Human Connectome Project
brain scan consumes 22MW of electricity – enough to power a nuclear submarine, BRAIN
is likely to be costlier than previous initiatives, and will need to carry a
substantial focus on making technological leaps in altogether new directions,
which are certainly needed in order to progress with the world’s exuberant
plans.
Amongst the plans the BRAIN Initiative advocates are:
- Solid academic expertise: NIH is due to form an academic leadership group comprising leading scientists to lay out clear scientific objectives, milestones, cost estimates and timetables for the initiative.
- Strong academia-industry collaboration: federal agencies are strongly encouraged to partner with companies and foundations with complementary interests, paving the way for a smooth transition from neuro-science to neuro-tech. In the past, such collaborations have strongly benefitted government plans, and feature prominently in the BRAIN initiative. All the US-based foundations and initiatives described in table 2 are expected to work closely with the BRAIN initiative.
- High ethical standards: because neuroscientific, or generally breakthrough, practices are likely to touch on ethically-sensitive bases at some point, the BRAIN initiative is preliminarily addressing potential issues via the President’s order to the Commission for the Study of Bioethical Issues for efforts to be partially diverted towards foreseeable or arising challenges in light of society, the law and ethics.
THE HUMAN BRAIN PROJECT
Since the Human Brain Project’s (HBP) inception in 2013 in
its birthplace Lausanne, proponents have likened it to the CERN for the brain,
whilst opponents have called it a flamboyant, and a much too feathery, peacock
of the sciences. The ambitions of the project are so grand that the necessary
supercomputer, befittingly titled “The Brain”, whose job would be to simulate
the inner workings of CNS headquarters, would take at least 12 years to build,
and each neuron it would simulate would guzzle the power of one laptop. The
Brain would devour every neuroscientific finding, brain scan, neuroanatomical
image and other imaginable parameters around the world, and process all that
information to potentially recreate the millions of neurons and synapses of the
mind, and simulate their behavior.
The Human Brain Project competed with other, no less ambitious
projects, for the modest sum of €1.19 billion over the next ten years. One
worthy challenger project, which also managed to secure substantial EU funds,
was 21st century’s miracle material graphene. In general, the main
goal of HBP is to slowly but steadily simulate every human brain neuron on the
computer, and HBP’s founder and, incidentally, Israel’s Weizmann Institute
graduate Henry Markram plans to accomplish this by the 2040s. Work towards this
objective is already underway: HBP’s prototype, titled the Blue Brain Project,
was launched by Markram in 2005 and by 2008 the first artificial neocortical
column of 10,000 rat brain cells was complete.
By 2011 the number of simulated rat neocortical columns stood at 100,
and the rat brain project is due to be completed in 2014. By the way, the $20
million supercomputer on which the Blue Brain Project runs costs $1 million a
year to cool with Lake Geneva’s water. So much for simulating an organ which
runs on the energy of a bedside lamp.
The human brain is orders of magnitude more complex than the
rat brain, but perhaps the most restricting factor in human brain simulation is
the fact that humans do not grow in labs, and neuroscientists are faced with
the immense quest of creating a unique approach to collecting human brain data
without having to genetically modify or dissect homo sapiens. This is
why HBP will be an omnipotent cohort of 150 (soon to be 1,500) top researchers
from 70 institutions in 22 countries, whose reach will branch far and wide into
the depths of the scientific and healthcare communities.
The chaotic complexity of HBP is undeniable, but the team
has broken the monster mission into manageable and very relevant parts. There
is the Neuroinformatics Platform, which aims to create a practical interface
for scientists around the world to share and homogenize their data, and the
Brain Simulation Platform which will make use and most importantly sense
of the collected information, and perform in silico research. Then there
are the High Performance Computing Platform, the Medical Informatics Platform,
the Neuromorphic Computing Platform and a Neurorobotics Platform. The platforms
are all based on previous pioneering work by the partners and, within 30
months, will be open for use by the world’s neuroscience community, growing in
magnitude from continuous input generated from research.
And then there is the ethical and public awareness committee, whose
important role is to present latest findings to the public so as to minimize
the project’s ability to cause unwarranted panic and misunderstanding, to the
possibility of which genetically modified produce could testify.
ISRAEL BRAIN TECHNOLOGIES
Israel is often referred to as the “Start-up Nation”, but Israel’s
president Shimon Peres is seemingly fascinated by a much further frontier than
that. From “Start-up Nation” to “Brain Nation” is how the recent non-profit
Israel Brain Technologies (IBT) initiative is commonly described. The main goal
of the initiative will be to steer Israel’s immense R&D efforts in a more
neuro-inspired direction, carrying the ultimate goal of making Israel a leading
neurotech hub of the world.
The initiative was conceived under President Peres’s firm
belief in the future of neurotechnology, but was put in motion by one of the
most successful entrepreneurs in Israel’s history—Dr Rafi Gidron, who was the
official founder of IBT and now serves as its chairman. Gidron founded an
optical component company Chromatis in 1998, and sold the company to Lucent
just 27 months later for $4.7 billion, in what has since become Israel’s
largest exit.
Gidron strongly supports the President’s vision to turn
Israel into the go-to neuro nation. After all, Peres was able to raise $250
million for nanotechnology research, and there isn’t a doubt that he could do
the same for neurotech. IBT is now entering its third year of operation, and already
over $10 million was raised for areas which form the focus of the initiative:
human-machine interface and neurological therapies.
Currently IBT is generating hype through its $1 million
prize offered for yet another brain acronym--the B.R.A.I.N. (Breakthrough
Research And Innovation in Neurotechnology) competition, which will see most
promising scientists around the globe lock horns over who will be the creator
of the most innovative technology around the world in the following spheres:
- Technology for diagnostics and treatment of brain disease
- Technology which can improve scientific understanding of the brain
- Groundbreaking brain-machine interface technology
- Innovative brain stimulation technology
- Disruptive neuro-technologies in computation, robotics and communications
Currently a team of leading researchers and neuro-experts
around the globe, which include three Nobel laureates Profs Eric Kandel, Daniel
Kahneman and Bert Sakmann, are selecting amogst a number of finalists of the Brain
Prize, which were announced in May of 2013. The winner will be revealed at
IBT’s Global Brain Technology conference in October 2013.
More info at www.IsraelBrain.org
No comments:
Post a Comment